PF-06952229

CAS No. 1801333-55-0

PF-06952229( PF06952229 )

Catalog No. M26371 CAS No. 1801333-55-0

PF-06952229 is an selective and orally active inhibitor of TGFbR1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 260 Get Quote
10MG 447 Get Quote
25MG 714 Get Quote
50MG 1017 Get Quote
100MG 1368 Get Quote
500MG 2673 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    PF-06952229
  • Note
    Research use only, not for human use.
  • Brief Description
    PF-06952229 is an selective and orally active inhibitor of TGFbR1.
  • Description
    PF-06952229 is an selective and orally active inhibitor of TGFbR1.(In Vivo):In MCF-7 ER+ HER2-xenograft breast cancer tumor model, PF-06952229 (30 mg/kg; gavage) combines with Palbociclib results in an improved inhibition of pSMAD2 and a significant increase in survival.
  • In Vitro
    ——
  • In Vivo
    PF-06952229 (oral gavage; 30 mg/kg; twice daily; 21 days) combines with Palbociclib 21 days results in an improved inhibition of pSMAD2 in the MCF7 ER+?xenograft breast cancer tumor model. This combination also leads to a significant increase in survival relative to PF-06952229 monotherapy. Animal Model:MCF-7 ER+?HER2-xenograft breast cancer tumor modelDosage:30 mg/kg Administration:Oral gavage; twice daily; 44 days Result:Resulted in an increase in tumor growth inhibition when combined with Palbociclib.
  • Synonyms
    PF06952229
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    MRP4| OAT1| OAT3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1801333-55-0
  • Formula Weight
    458.92
  • Molecular Formula
    C23H24ClFN4O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (108.95 mM)
  • SMILES
    CC(C)c1cnc(cc1Nc1ccncc1C(=O)NC(CO)CO)-c1cc(Cl)ccc1F
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kamiński T, Micha?owska M, Pawlak D. Aryl hydrocarbon receptor (AhR) and its endogenous agonist - indoxyl sulfate in chronic kidney disease. Postepy Hig Med Dosw (Online). 2017 Jul 30;71(0):624-632. Review.
molnova catalog
related products
  • Lophanthoidin F

    Lophanthoidin F is a kind of natural product derived from the herbs of Rabdosia lophanthoides.

  • Diclofenac diethylam...

    Diclofenac Diethylamine is a non-selective COX inhibitor used as a nonsteroidal anti-inflammatory drug (NSAID).

  • Atractylochromene

    Atractylochromene is an inhibitor of β-catenin dependent Wnt pathway, it may be a potential chemotherapeutic agent for the prevention and treatment of human colon cancer.